300171.SZ
东富龙
SZSE · Healthcare · C 制造业 · CN
CNY 13.77
−4.57%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
45.3x
EV/EBITDA
19.2x
Market Cap
CNY 10.54B
MomentumView details →
1D Return
−4.57%
YTD Return
−10.64%
RSI (14)
51.8
ValuationView details →
P/E (Fwd)
45.3x
EV/EBITDA
19.2x
Market Cap
CNY 10.54B
RSI (14)
51.8
MomentumView details →
1D Return
−4.57%
YTD Return
−10.64%
Similar companies
Latest newsMore news →
Dongfulong announced its first-half 2026 results: revenue of 2.535 billion yuan, up 4.37% year-on-year, and net profit attributable to shareholders of 108 million yuan, up 134.49% from 45.9195 million yuan in the same period of 2025.9d agoDongfulong announced an interim cash dividend of 0.66 yuan per 10 shares (tax included), based on a share capital of 761 million shares after excluding 4.98 million shares held in the repurchase account.9d ago